Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
0.5
%
2,15%
Latest
23.8
High
25.6
Low
23.5
Volume
49 944
Turnover (SEK)
1 219 602
Value (MSEK)
249,0

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Fredrik Juserius
  • Joen Luirink

Videos

Largest Owners

Name Capital % Votes % Date
Nordnet Pensionsförsäkring 12,06 12,06 2021-06-30
Avanza Pension 11,77 11,77 2021-06-30
Anders Ericsson 6,66 6,66 2021-02-08
Magnus Linderoth 6,07 6,07 2021-06-30
Jan-Willem De Gier 5,71 5,71 2021-06-30
Joen Luirink 5,58 5,58 2021-06-30
Anders Wall Stiftelser 5,06 5,06 2021-06-30
John Moll 4,90 4,90 2021-02-08
Johan Källstrand 4,20 4,20 2021-06-30
Maria Alrikson 2,48 2,48 2021-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Upcoming reports

  • 2021-11-10 Delårsrapport 2021-Q3

  • 2022-02-23 Bokslutskommuniké 2021